Xybion and Locus team up on animal and preclinical data management

By Gareth Macdonald

- Last updated on GMT

Related tags: Pre-clinical development

US firms Xybion Medical Systems and Locus Technology say their new animal management and data analysis partnership will help streamline preclinical development and reduce research costs.

New Jersey based Xybion specialises in providing the drug and preclinical research industries with toxicology and pathology data management software, primarily through its Pristima platform.

Locus, which is headquartered in Maryland, provides contract research organisations (CROs) with a range animal management services, including breeding, the application of Institutional Animal Care and Use Committee (IACUC) protocols and animal welfare through its LabTracks software.

The new accord combines Pristima with LabTracks in an approach that Xybion CEO Pradip Banerjee said will meet growing industry demand for a software solution capable of managing all aspects of a CRO’s business.

Dr Banerjee explained that: “We listened to our customers and the medical research community as they told us that they need a single source to provide research facility and preclinical study management.

After meeting with the leaders in the industry and looking at the commercial products in use in research facilities, we are confident that Locus Technology has done the best job of developing a comprehensive solution​.”

David Larkins, Locus’ president agreed about growing demand, suggesting the “research industry needs improved solutions to work smarter, [and have] streamlined access to and analysis of critical data, and a conduit to overall research cost reduction​.”

Any solution that helps reduce costs is likely to catch the eye of most CROs, particularly those focused on preclinical research which have struggled this year as a result of cautious drug industry R&D spending.

Animal focus

The deal is not the first research animal focused accord that Xybion has signed this year. In March, the firm teamed up with Pennsylvania’s Instech Solomon to integrate the former’s Orchestra infusion system with its laboratory information system.

Related news

Related products

show more

What’s Next for mRNA?

What’s Next for mRNA?

Catalent Pharma Solutions | 27-Jan-2022 | Insight Guide

Now that the pharma industry and regulators have significant data on safety and efficacy of mRNA vaccines, many companies are looking beyond infectious...

SmartSignals Study Oversight

SmartSignals Study Oversight

Signant Health | 24-Jan-2022 | Product Brochure

Today, sponsors and study teams often struggle to support the growing variety and volume of clinical data. The right technology thought will help your...

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

Planning Your Preclinical Assessment

Planning Your Preclinical Assessment

Altasciences | 17-Jan-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

Related suppliers

Follow us


View more